Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply

N Engl J Med. 2023 Jan 19;388(3):284. doi: 10.1056/NEJMc2215181.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Hypopigmentation*
  • Nitriles
  • Pyrimidines
  • Vitiligo* / drug therapy

Substances

  • ruxolitinib
  • Nitriles
  • Pyrimidines